Crossmark

Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class

Published Print: 2021-10

Authors

Porta-Etessam, J.

González-García, N.

Guerrero, Á.L.

García-Azorín, D.
License Information

Text and Data Mining valid from 2021-10-01

Version of Record valid from 2021-06-30
More Information

This article is maintained by: Elsevier

Article Title: Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class

Journal Title: Neurología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nrleng.2020.10.008

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.nrl.2020.10.009

Content Type: simple-article

Copyright: © 2020 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current